SSG
CERE

Summit Securities Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Summit Securities Group’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,001
Closed -$491K – 820
2024
Q2 		$491K Buy
+12,001
New +$491K 0.09% 39